The development of physiologically relevant human models for neurological diseases remains a challenge for pre-clinical drug discovery. With the emergence of human induced pluripotent stem cell (iPSC)-technology, it is now possible to design and manufacture cell types that are critical players in neural disease pathogenesis, such as neurons, astrocytes and microglia. These iPSC-derivatives retain their patient-specific genetic backgrounds and demonstrate clinically relevant phenotypes.
They, therefore, can serve as human in vitro platforms to accelerate the drug development pipeline. A first challenge to implementing iPSCs for drug discovery is the reproducible and large-scale generation of high quality and functional differentiated derivatives. During this webinar we will discuss the advantages and challenges of manufacturing and co-culturing iPSC-derived neuronal models for disease modeling, assay development and drug testing purposes.
In this webinar you will learn:
-
The benefits of using iPSC-derived neuronal models for drug discovery
-
Key considerations for the large-scale generation of functional human iPSC-derived neuronal cells
-
Insights into co-culturing possibilities of iPSC-derived neurons, astrocytes and microglia.
![3bef8cc75bbf5e99-450x0-0-files-Events-Replay_02-Webinar-Manufacture-amp-co-culture-of-human-iPSC-derived-neuronal-cells](https://www.ncardia.com/hs-fs/hubfs/3bef8cc75bbf5e99-450x0-0-files-Events-Replay_02-Webinar-Manufacture-amp-co-culture-of-human-iPSC-derived-neuronal-cells.png?width=350&height=197&name=3bef8cc75bbf5e99-450x0-0-files-Events-Replay_02-Webinar-Manufacture-amp-co-culture-of-human-iPSC-derived-neuronal-cells.png)
Fill in the form below to watch the replay: